| For: | Couñago F, Luna J, Guerrero LL, Vaquero B, Guillén-Sacoto MC, González-Merino T, Taboada B, Díaz V, Rubio-Viqueira B, Díaz-Gavela AA, Marcos FJ, del Cerro E. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions. World J Clin Oncol 2019; 10(10): 318-339 [PMID: 31799148 DOI: 10.5306/wjco.v10.i10.318] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i10/318.htm |
| Number | Citing Articles |
| 1 |
David D. Greenberg. CORR Insights®: Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?. Clinical Orthopaedics & Related Research 2020; 478(11) doi: 10.1097/CORR.0000000000001315
|
| 2 |
Doo Yong Chung, Dong Hyuk Kang, Hae Do Jung, Joo Yong Lee, Do Kyung Kim, Jee Soo Ha, Jinhyung Jeon, Kang Su Cho. Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis. Investigative and Clinical Urology 2023; 64(3) doi: 10.4111/icu.20230058
|
| 3 |
Hongfu Sun, Minghao Li, Wei Huang, Jian Zhang, Shihong Wei, Yongjing Yang, Zhongtang Wang, Shucheng Ye, Heyi Gong, Yaowen Zhang, Jie Li, Haixia Song, Lifang Wang, Xiangming Chen, Haiqun Lin, Gaofeng Ding, Hongwei Li, Anping Zheng, Xuezhen Ma, ShaoShui Chen, Liping Liu, Kaixian Zhang, Chengrui Fu, Wenzhi Liu, Jing Wang, Xiaqin Zhang, Tingting Liu, Dan Han, Qian Zhao, Peipei Wu, Qianqian Yuan, LiJun Tian, Ping Zhang, Xueqin Wu, Fei Chen, Zicheng Zhang, Baosheng Li.
Thoracic Radiotherapy Improves the Survival in Patients With
EGFR
-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
. Journal of Clinical Oncology 2025; 43(4) doi: 10.1200/JCO.23.02075
|
| 4 |
Mohammad Ali Tajik-Mansoury, Ji N. Lee, Ravneet Kaur, Shailja Patel, Nelly Ju, Khinh Ranh Voong, Reza Farjam. Advancing stereotactic body radiotherapy through off-axis beam optimization to enable safer treatment of multi-isocenter coplanar targets. Physics and Imaging in Radiation Oncology 2026; 40 doi: 10.1016/j.phro.2026.101029
|
| 5 |
Yi-Hsing Chen, Ue-Cheung Ho, Lu-Ting Kuo. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update. Cancers 2022; 14(5) doi: 10.3390/cancers14051350
|
| 6 |
Dung-Tsa Chen, Wenyaw Chan, Zachary J. Thompson, Ram Thapa, Amer A. Beg, Andreas N. Saltos, Alberto A. Chiappori, Jhanelle E. Gray, Eric B. Haura, Trevor A. Rose, Ben Creelan, Wei Wang. Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer. PLOS ONE 2021; 16(7) doi: 10.1371/journal.pone.0252041
|
| 7 |
E. Dansin, F. Le Tinier, L. Brouchet, A. Desmet, C. Massabeau, P. Van Houtte, J. Khalifa. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques. Revue des Maladies Respiratoires Actualités 2020; 12(2) doi: 10.1016/S1877-1203(20)30090-2
|
| 8 |
Felipe Couñago, Oscar Juan, Javier Garde-Noguera, Xabier Mielgo-Rubio. Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study. World Journal of Clinical Oncology 2020; 11(12): 983-989 doi: 10.5306/wjco.v11.i12.983
|
| 9 |
C. Faivre-Finn, N. Venissac, B. Besse, E. Dansin, D. Moro-Sibolot. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques. Revue des Maladies Respiratoires Actualités 2021; 13(2) doi: 10.1016/S1877-1203(21)00104-X
|
| 10 |
Francesca Di Pressa, Fabiana Perrone, Anna Benini, Frank Lohr, Marcello Tiseo, Alessio Bruni. Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach. Exploration of Targeted Anti-tumor Therapy 2024; 5(3) doi: 10.37349/etat.2024.00228
|
| 11 |
Sameh Daher, Walid Shalata, Natali Shirron, Talia Shentzer, Tal Goshen-Lago, Lior Biras, Mor Moskovitz, Sivan Shamai, Damien Urban, Hadas Gantz-Sorotsky, Anastasiya Lobachov, Julia Dudnik, Aharon Yehonatan Cohen, Alexander Yakobson, Alona Zer, Jair Bar. Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study. JTO Clinical and Research Reports 2026; 7(5) doi: 10.1016/j.jtocrr.2026.100981
|
| 12 |
Katsuhiro Hayashi, Hiroyuki Tsuchiya. The role of surgery in the treatment of metastatic bone tumor. International Journal of Clinical Oncology 2022; 27(8) doi: 10.1007/s10147-022-02144-6
|
| 13 |
Caleb J. Euhus, Taylor R. Ripley, Cristian G. Medina. The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer. Cancers 2022; 14(10) doi: 10.3390/cancers14102524
|
| 14 |
Sankha Bhattacharya. The Incredible Potential of Exosomes as Biomarkers in the Diagnosis of
Colorectal Cancer. Current Drug Research Reviews 2022; 14(3) doi: 10.2174/2665998002666220501164429
|
| 15 |
Eva Yu-Hsuan Chuang, Chiao-En Wu, Tzu-Wei Kuo, Yu-Wen Wen, Ping-Chih Hsu, Chih-Hsi Scott Kuo, Cheng-Ta Yang, Ling-Jen Hung, Yin-Kai Chao. Evaluating the Impact of Primary Tumor Resection on EGFR-TKI-treated Patients with Advanced Lung Cancer: A Multicenter Propensity-matched Study. Journal of Cancer Research and Practice 2025; 12(2) doi: 10.4103/ejcrp.eJCRP-D-24-00037
|
| 16 |
Sharareh Seifi, Sara Shiari, Mihan Pourabdollah, Seyedeh Faezeh Sadatkiaei, Mohsen Salimi. Solitary isolated renal metastasis from lung squamous cell carcinoma: a case report and comprehensive review of the literature. International Cancer Conference Journal 2026; doi: 10.1007/s13691-026-00888-w
|
| 17 |
Eunji Choi, Sophia J Luo, Jacqueline V Aredo, Leah M Backhus, Lynne R Wilkens, Chloe C Su, Joel W Neal, Loïc Le Marchand, Iona Cheng, Heather A Wakelee, Summer S Han. The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer. JNCI: Journal of the National Cancer Institute 2022; 114(4) doi: 10.1093/jnci/djab224
|
| 18 |
Abhishek Mahato, Gaurav P.S. Gahlot, Deepak Kumar Jha, Rajhans Rajhans. Inguinal Lymphadenopathy: A Rare Initial Site of Metastatic Lung Carcinoma. World Journal of Nuclear Medicine 2022; 21(04) doi: 10.1055/s-0042-1750397
|
| 19 |
Huan Ding, Li Shi, Zhuo Chen, Yi Lu, Zhiyu Tian, Hongyu Xiao, Xiaojing Deng, Peiyi Chen, Yue Zhang. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01341-6
|
| 20 |
Leilei Wu, Zhenshan Zhang, Menglin Bai, Yujie Yan, Jinming Yu, Yaping Xu. Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms, current state, challenges, and orientations. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01139-8
|
| 21 |
Rong Ma, Qian Zhao, Ren Zhao, Juan Li, Yan-Yang Wang. Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer. Nuclear Medicine Communications 2022; 43(9) doi: 10.1097/MNM.0000000000001599
|
| 22 |
Felipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima, Ivan Felizardo Contrera Toro, Thiago Ferreira de Souza, Bárbara Juarez Amorim, Aristoteles Souza Barbeiro, Elba Etchebehere. The ratio between the whole-body and primary tumor burden, measured on 18F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancer. Radiologia Brasileira 2021; 54(5) doi: 10.1590/0100-3984.2020.0054
|
| 23 |
Andrew M. Mendez, Elena N. Petre, Etay Ziv, Fourat Ridouani, Stephen B. Solomon, Vlasios Sotirchos, Ken Zhao, Erica S. Alexander. Safety and efficacy of thermal ablation of adrenal metastases secondary to lung cancer. Surgical Oncology 2024; 55 doi: 10.1016/j.suronc.2024.102102
|
| 24 |
Felipe Couñago, Nuria Rodríguez de Dios, Javier Luna, Rodolfo Chicas-Sett, Patricia Calvo, Joaquín Cabrera-Rodriguez, Andrea Bobo, Arturo Navarro-Martin, Castalia Fernández. Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?. World Journal of Clinical Oncology 2022; 13(2): 101-115 doi: 10.5306/wjco.v13.i2.101
|
| 25 |
Rodolfo Chicas-Sett, Juan Zafra-Martin, Ignacio Morales-Orue, Juan Castilla-Martinez, Miguel A. Berenguer-Frances, Elisa Gonzalez-Rodriguez, Delvys Rodriguez-Abreu, Felipe Couñago. Immunoradiotherapy as an Effective Therapeutic Strategy in Lung Cancer: From Palliative Care to Curative Intent. Cancers 2020; 12(8) doi: 10.3390/cancers12082178
|
| 26 |
Kuo Li, Xiaonian Cao, Bo Ai, Han Xiao, Quanfu Huang, Zheng Zhang, Qian Chu, Li Zhang, Xiaofang Dai, Yongde Liao. Salvage surgery following downstaging of advanced non‐small cell lung cancer by targeted therapy. Thoracic Cancer 2021; 12(15) doi: 10.1111/1759-7714.14044
|
| 27 |
Satoshi Kato, Satoru Demura, Ryo Kitagawa, Noriaki Yokogawa, Takaki Shimizu, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Hideki Murakami, Norio Kawahara, Hiroyuki Tsuchiya. Clinical outcomes following total en bloc spondylectomy for spinal metastases from lung cancer. Journal of Orthopaedic Science 2024; 29(3) doi: 10.1016/j.jos.2023.04.007
|
| 28 |
Ngoc-Quynh Chu, Orly Yariv, Smita Sihag, Daniel Gomez. Hybrid Approaches to Local Management of Pulmonary Metastatic Disease. Thoracic Surgery Clinics 2025; 35(2) doi: 10.1016/j.thorsurg.2024.11.009
|
| 29 |
Mónika Blake-Cerda, Francisco Lozano-Ruíz, Federico Maldonado-Magos, Dolores de la Mata-Moya, Diego Díaz-García, Luis Lara-Mejía, Zyanya Lucia Zatarain-Barrón, María-Fernanda Cuevas-Góngora, Feliciano Barron-Barron, José Francisco Corona-Cruz, Luis Cabrera-Miranda, Marisol Arroyo-Hernández, Raquel Gerson, Oscar Arrieta. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study. Lung Cancer 2021; 152 doi: 10.1016/j.lungcan.2020.12.029
|
| 30 |
Atallah Baydoun, VeAnn L. Lee, Tithi Biswas. Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials. Cancers 2022; 14(21) doi: 10.3390/cancers14215339
|
| 31 |
Anson Man Lok Yeung, James Chung Hang Chow. Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review. Clinical Lung Cancer 2026; 27(2) doi: 10.1016/j.cllc.2026.01.003
|
| 32 |
Felipe Couñago, Juan Carlos Trujillo-Reyes, Xabier Mielgo-Rubio, O Juan Vidal, Lira Pelari-Mici, Inigo Royo Crespo, Miriam López-Mata, Andres Obeso, Margarita Martín-Martín, Javier Garde-Noguera. Current treatment landscape for oligometastatic non-small cell lung cancer. World Journal of Clinical Oncology 2022; 13(6): 485-495 doi: 10.5306/wjco.v13.i6.485
|
| 33 |
Lukas Käsmann. Advances in Radiation Oncology in Lung Cancer. Medical Radiology 2022; doi: 10.1007/174_2022_339
|
| 34 |
Meghana Maddula, Annelise Decaria, Bea Brown, John Simes, Michael Boyer, Venessa Chin. Assessing Second‐Line Treatment Strategies and Outcomes in Epidermal Growth Factor Receptor (EGFR) Oncogene‐Driven Stage IV Non‐Small Cell Lung Cancer, Following a First‐Line EGFR‐TKI Therapy. Cancer Reports 2025; 8(12) doi: 10.1002/cnr2.70428
|
| 35 |
|
| 36 |
Arsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, Valentino Martelli, Giulia Corrao, Giuseppe Lo Russo, Claudia Proto, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Carlo Genova, Barbara Alicja Jereczek-Fossa, Filippo de Braud, Marina Chiara Garassino, Sara Elena Rebuzzi. Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression. Cancers 2021; 13(6) doi: 10.3390/cancers13061300
|
| 37 |
Jeong Uk Lim. Management of Oligometastasis and Oligoprogression in Patients with Epidermal Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation Tyrosine Kinase Inhibitors. Clinical Lung Cancer 2021; 22(5) doi: 10.1016/j.cllc.2021.03.004
|
| 38 |
Mauro Francesco Pio Maiorano, Brigida Anna Maiorano. Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1620922
|
| 39 |
Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Takaki Shimizu, Hideki Murakami, Norio Kawahara, Katsuro Tomita, Hiroyuki Tsuchiya. Surgical Metastasectomy in the Spine: A Review Article. The Oncologist 2021; 26(10) doi: 10.1002/onco.13840
|
| 40 |
Hae Lin Cho, Tracy Balboni, Sebastian Matthias Christ, Brandon Turner, Alexander Spektor, Subha Perni. Is Oligometastatic Cancer Curable? A Survey of Oncologist Perspectives, Decision Making, and Communication. Advances in Radiation Oncology 2023; 8(5) doi: 10.1016/j.adro.2023.101221
|
| 41 |
Céline Goffinet, H. Marshall, Ian A. Yang, R.V. Bowman, Kwun M. Fong. Encyclopedia of Respiratory Medicine. 2022; doi: 10.1016/B978-0-08-102723-3.00049-4
|
| 42 |
Donghee Kim, Geun Dong Lee, Hyeong Ryul Kim, Jae Kwang Yun. Reshaping the robotic learning curve in anatomic lung resection: the role of prior video-assisted thoracoscopic surgery experience in a multi-surgeon single-center series. Journal of Robotic Surgery 2025; 20(1) doi: 10.1007/s11701-025-03054-1
|
| 43 |
François Montagne, Florian Guisier, Nicolas Venissac, Jean-Marc Baste. The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art. Cancers 2021; 13(15) doi: 10.3390/cancers13153711
|
| 44 |
Neal Andruska, Hayley B. Stowe, Cathryn Crockett, Wei Liu, David Palma, Corinne Faivre-Finn, Shahed N. Badiyan. Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios. Journal of Thoracic Oncology 2021; 16(7) doi: 10.1016/j.jtho.2021.04.002
|
| 45 |
Markéta Kepičová, Lubomír Tulinský, Adéla Kondé, Paula Dzurňáková, Peter Ihnát, Dávid Adamica, Čestmír Neoral, Lubomír Martínek. Risk Factors and Postoperative Complications of Lobectomy for Non-Small Cell Lung Cancer: An Exploratory Analysis of Premedication and Clinical Variables. Medicina 2024; 60(12) doi: 10.3390/medicina60122088
|
| 46 |
Heqiao Han, Lian Li, Taiwon Park, Yuzhao Yang, Guha Alai, Chuan Zhong, Yidan Lin. Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1820515
|
| 47 |
Satoshi Kato, Satoru Demura, Hideki Murakami, Kazuya Shinmura, Noriaki Yokogawa, Ryohei Annen, Motoya Kobayashi, Yohei Yamada, Satoshi Nagatani, Norio Kawahara, Hiroyuki Tsuchiya. Medium to Long-Term Clinical Outcomes of Spinal Metastasectomy. Cancers 2022; 14(12) doi: 10.3390/cancers14122852
|
| 48 |
Mihriban Erdoğan, Gönül Demir, Zeliha Güzelöz, Ferhat Eyiler, Cüneyt Ebruli, Olçun Ümit Ünal, Murat Keser, Mustafa Emiroğlu. Radiotherapy in Oligometastatic and Oligoprogressive Disease. The Journal of Tepecik Education and Research Hospital 2023; 33(1) doi: 10.4274/terh.galenos.2021.70487
|